表紙:抗凝固剤拮抗薬の市場シェア:規模、動向、業界分析、製品、流通チャネル、地域のセグメント別予測(2021年~2028年)
市場調査レポート
商品コード
1021150

抗凝固剤拮抗薬の市場シェア:規模、動向、業界分析、製品、流通チャネル、地域のセグメント別予測(2021年~2028年)

Anticoagulant Reversal Drugs Market Share, Size, Trends, Industry Analysis Report, By Product ; By Distribution Channel ; By Regions; Segment Forecast, 2021 - 2028

出版日: | 発行: Polaris Market Research | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.03円
抗凝固剤拮抗薬の市場シェア:規模、動向、業界分析、製品、流通チャネル、地域のセグメント別予測(2021年~2028年)
出版日: 2021年05月01日
発行: Polaris Market Research
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗凝固剤拮抗薬の市場規模は、2028年には22億米ドルに達すると予測されています。

当レポートは、世界の抗凝固剤拮抗薬市場について調査しており、市場規模や予測、動向、成長および抑制要因、機会や課題、製品・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

  • レポート概要
    • 調査の目的
    • 市場範囲
    • 前提条件
  • ステークホルダー

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • 情報源

第4章 市場の洞察

  • 業界のスナップショット
  • 市場力学
    • 成長要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
  • PESTLE分析
  • 市場業界の動向
  • COVID-19インパクト分析

第5章 製品タイプ別:市場評価

  • 主な調査結果
  • イントロダクション
    • 世界市場:製品タイプ(2016-2028)
  • プロトロンビン複合体濃縮物
    • 世界の抗凝固剤拮抗薬市場、プロトロンビン複合体濃縮物、地域別(2016-2028)
  • フィトナジオン
    • 世界の抗凝固剤拮抗薬市場、フィトナジオン、地域別(2016-2028)
  • アンデキサネットアルファ
    • 世界の抗凝固剤拮抗薬市場、アンデキサネットアルファ、地域別(2016-2028)
  • イダルシズマブ
    • 世界の抗凝固剤拮抗薬市場、イダルシズマブ、地域別(2016-2028)
  • プロタミン
    • 世界の抗凝固剤拮抗薬市場、プロタミン、地域別(2016-2028)
  • その他
    • 世界の抗凝固剤拮抗薬市場、その他、地域別(2016-2028)

第6章 流通チャネル別:世界市場

  • 主な調査結果
  • イントロダクション
    • 世界の抗凝固剤拮抗薬市場、流通チャネル別(2016-2028)
  • 病院薬局
    • 世界の抗凝固剤拮抗薬市場、病院薬局、地域別(2016-2028)
  • 小売薬局
    • 世界の抗凝固剤拮抗薬市場、小売薬局、地域別(2016-2028)
  • オンライン薬局
    • 世界の抗凝固剤拮抗薬市場、オンライン薬局、地域別(2016-2028)

第7章 地域別:市場評価

  • 主な調査結果
  • イントロダクション
    • 抗凝固剤拮抗薬市場評価、地域(2016-2028)
  • 抗凝固剤拮抗薬市場-北米
    • 北米:抗凝固剤拮抗薬市場、製品タイプ(2016-2028)
    • 北米:抗凝固剤拮抗薬市場、流通チャネル別(2016-2028)
    • 米国
    • カナダ
  • 抗凝固剤拮抗薬市場-欧州
    • 欧州:抗凝固剤拮抗薬市場、製品タイプ(2016-2028)
    • 欧州:抗凝固剤拮抗薬市場、流通チャネル別(2016-2028)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • オーストリア
  • 抗凝固剤拮抗薬市場-アジア太平洋
    • アジア太平洋:抗凝固剤拮抗薬市場、製品タイプ(2016-2028)
    • アジア太平洋:抗凝固剤拮抗薬市場、流通チャネル別(2016-2028)
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 抗凝固剤拮抗薬市場-中東およびアフリカ
    • 中東・アフリカ:抗凝固剤拮抗薬市場、製品タイプ(2016-2028)
    • 中東・アフリカ:抗凝固剤拮抗薬市場、流通チャネル別(2016-2028)
    • サウジアラビア
    • UAE
    • イスラエル
    • 南アフリカ
  • 抗凝固剤拮抗薬市場-ラテンアメリカ
    • ラテンアメリカ:抗凝固剤拮抗薬市場、製品タイプ(2016-2028)
    • ラテンアメリカ:抗凝固剤拮抗薬市場、流通チャネル別(2016-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第8章 競合情勢

  • 拡張および買収分析
    • 拡張
    • 買収
  • 提携/協業/契約/公開

第9章 企業プロファイル

  • Portola Pharmaceuticals
  • Boehringer Ingelheim
  • CSL Behring
  • Bausch Health Companies Inc.
  • Octapharma AG
  • SGPharma Pvt. Ltd.
  • Alps Pharmaceutical Ind. Co., Ltd.
  • Fresenius Kabi AG
  • Pfizer, Inc.
  • AMAG Pharmaceuticals, Inc.
  • Dr. Reddy's Laboratories
図表

Truncated List of Tables

  • Table 1 Global Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 2 Global Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 3 Anticoagulant Reversal Drugs Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • Table 4 North America: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 5 North America: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 6 U.S.: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 7 U.S.: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 8 Canada: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 9 Canada: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 10 Europe: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 11 Europe: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 12 UK: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 13 UK: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 14 France: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 15 France: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 16 Germany: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 17 Germany: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 18 Italy: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 19 Italy: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 20 Spain: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 21 Spain: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 22 Netherlands: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 23 Netherlands: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 24 Austria: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 25 Austria: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 26 Asia Pacific: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 27 Asia Pacific: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 28 China: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 29 China: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 30 India: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 31 India: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 32 Malaysia: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 33 Malaysia: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 34 Japan: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 35 Japan: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 36 Indonesia: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 37 Indonesia: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 38 South Korea: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 39 South Korea: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 40 Middle East & Africa: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 41 Middle East & Africa: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 42 Saudi Arabia: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 43 Saudi Arabia: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 44 UAE: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 45 UAE: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 46 Israel: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 47 Israel: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 48 South Africa: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 49 South Africa: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 50 Latin America: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 51 Latin America: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 52 Mexico: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 53 Mexico: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 54 Brazil: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 55 Brazil: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • Table 56 Argentina: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • Table 57 Argentina: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)

Truncated List of Figures

Figure 1 Market Highlights (2020, Revenue)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top Down & Bottom Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Product Type

Figure 7 Global Anticoagulant Reversal Drugs Market, By Product Type, 2020 & 2028 (USD Million)

Figure 8 Market by Distribution Channel

Figure 9 Global Anticoagulant Reversal Drugs Market, By Distribution Channel, 2020 & 2028 (USD Million)

Figure 10 Anticoagulant Reversal Drugs Market Assessment, By Geography, 2016 - 2028 (USD Million)

Figure 11 Strategic Analysis - Anticoagulant Reversal Drugs Market

目次
Product Code: PM1869

The global anticoagulant reversal drugs market size is expected to reach USD 2.20 billion by 2028 according to a new study by Polaris Market Research. The report "Anticoagulant Reversal Drugs Market Share, Size, Trends, Industry Analysis Report, By Product (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy); By Regions; Segment Forecast, 2021 - 2028" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Most common bleeding disorders include hemophilia A and B, and Von Willebrand disease (VWD). As per the data published by the National Hemophilia Foundation (NHF), in the U.S alone, more than 30,000 to 33,000 million people are suffering from hemophilia, and around 60% were accounted for the lethal form.

VWD is one of the common forms affecting one in every 100 people. Such bleeding disorders affect blood clotting and are expected to result in excessive bleeding both inside and outside the body. This extensive bleeding can cause death in individuals and necessitates the use of anticoagulant reveral drugs.

Certain surgeries such as atrial fibrillation, ischemic stroke, pulmonary embolism, heart-related ailments, and deep vein thrombosis require anticoagulants. As per the estimates of the CDC, over 2% of the people aged below 65 years suffer from atrial fibrillation, while 9% aged above 65 years usually develop this condition. It is also predicted that by 2030 around 12.1 million people will develop such conditions. It is also being estimated that around 60,000-100,000 U.S. individuals suffer die from deep vein thrombosis.

North America market accounted for the highest revenue share in 2020 and is expected to maintain its dominance over the forecast period. This can be attributed to the easy availability of the anticoagulant reversal drugs, high consumer expenditure in the healthcare sector, and favorable healthcare-related policies for consumers in U.S. and Canada.

However, Asia Pacific anticoagulant reversal drugs industry is projected to witness the fastest market growth rate over the study period. This growth is due to growing cases of bleeding disorders in the huge population in emerging economies.

Moreover, increased medical attention and awareness of the disease among individuals also supporting the region's market growth. Increased attention of the key players in the market in the booming region also complemented its market growth for anticoagulant reversal drugs.

Market participants such Portola Pharmaceuticals, CSL Behring, Bausch Health Companies Inc., Alps Pharmaceutical Ind. Co., Ltd, Boehringer Ingelheim, Octapharma AG, AMAG Pharmaceuticals, Inc., Pfizer, Inc., Dr. Reddy's Laboratories, SG Pharma Pvt Ltd., and Fresenius Kabi AG.

Polaris Market Research has segmented the anticoagulant reversal drugs market report on the basis of product, distribution channel and region:

Anticoagulant Reversal Drugs, Product Outlook (Revenue - USD Million, 2016 - 2028)

Prothrombin Complex Concentrates

Phytonadione

Andexanet Alfa

Idarucizumab

Protamine

Others

Anticoagulant Reversal Drugs, Distribution Channel Outlook (Revenue - USD Million, 2016 - 2028)

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Anticoagulant Reversal Drugs, by Regional Outlook (Revenue - USD Million, 2016 - 2028)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Anticoagulant Reversal Drugs Market Insights

  • 4.1. Anticoagulant Reversal Drugs - Industry snapshot
  • 4.2. Anticoagulant Reversal Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in prevalence of bleeding disorders
      • 4.2.1.2. Emergence of innovative therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Product Type recalls
      • 4.2.2.2. Side effects of drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Anticoagulant Reversal Drugs Market Industry trends
  • 4.6. COVID-19 Impact Anlaysis

5. Anticoagulant Reversal Drugs Market Assessment by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
  • 5.3. Prothrombin Complex Concentrates
    • 5.3.1. Global Anticoagulant Reversal Drugs Market, by Prothrombin Complex Concentrates, by Region, 2016 - 2028 (USD Million)
  • 5.4. Phytonadione
    • 5.4.1. Global Anticoagulant Reversal Drugs Market, by Phytonadione, by Region, 2016 - 2028 (USD Million)
  • 5.5. Andexanet Alfa
    • 5.5.1. Global Anticoagulant Reversal Drugs Market, by Andexanet Alfa, by Region, 2016 - 2028 (USD Million)
  • 5.6. Idarucizumab
    • 5.6.1. Global Anticoagulant Reversal Drugs Market, by Idarucizumab, by Region, 2016 - 2028 (USD Million)
  • 5.7. Protamine
    • 5.7.1. Global Anticoagulant Reversal Drugs Market, by Protamine, by Region, 2016 - 2028 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Anticoagulant Reversal Drugs Market, by Others, by Region, 2016 - 2028 (USD Million)

6. Global Anticoagulant Reversal Drugs Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • 6.3. Hospital Pharmacy
    • 6.3.1. Global Anticoagulant Reversal Drugs Market, by Hospital Pharmacy, By Region, 2016 - 2028 (USD Million)
  • 6.4. Retail Pharmacy
    • 6.4.1. Global Anticoagulant Reversal Drugs Market, by Retail Pharmacy, by Region, 2016 - 2028 (USD Million)
  • 6.5. Online Pharmacy
    • 6.5.1. Global Anticoagulant Reversal Drugs Market, by Online Pharmacy, by Region, 2016 - 2028 (USD Million)

7. Anticoagulant Reversal Drugs Market Assessment by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Anticoagulant Reversal Drugs Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • 7.3. Anticoagulant Reversal Drugs Market - North America
    • 7.3.1. North America: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
    • 7.3.2. North America: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.3.3. Anticoagulant Reversal Drugs Market - U.S.
      • 7.3.3.1. U.S.: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.3.3.2. U.S.: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.3.4. Anticoagulant Reversal Drugs Market - Canada
      • 7.3.4.1. Canada: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.3.4.2. Canada.: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • 7.4. Anticoagulant Reversal Drugs Market - Europe
    • 7.4.1. Europe: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
    • 7.4.2. Europe: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.4.3. Anticoagulant Reversal Drugs Market - UK
      • 7.4.3.1. UK: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.4.3.2. UK: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.4.4. Anticoagulant Reversal Drugs Market - France
      • 7.4.4.1. France: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.4.4.2. France: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.4.5. Anticoagulant Reversal Drugs Market - Germany
      • 7.4.5.1. Germany: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.4.5.2. Germany: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.4.6. Anticoagulant Reversal Drugs Market - Italy
      • 7.4.6.1. Italy: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.4.6.2. Italy: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.4.7. Anticoagulant Reversal Drugs Market - Spain
      • 7.4.7.1. Spain: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.4.7.2. Spain: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.4.8. Anticoagulant Reversal Drugs Market - Netherlands
      • 7.4.8.1. Netherlands: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.4.8.2. Netherlands: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.4.9. Anticoagulant Reversal Drugs Market - Austria
      • 7.4.9.1. Austria: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.4.9.2. Austria: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • 7.5. Anticoagulant Reversal Drugs Market - Asia-Pacific
    • 7.5.1. Asia Pacific: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
    • 7.5.2. Asia Pacific: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.5.3. Anticoagulant Reversal Drugs Market - China
      • 7.5.3.1. China: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.5.3.2. China: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.5.4. Anticoagulant Reversal Drugs Market - India
      • 7.5.4.1. India: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.5.4.2. India.: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.5.5. Anticoagulant Reversal Drugs Market - Malaysia
      • 7.5.5.1. Malaysia: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.5.5.2. Malaysia: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.5.6. Anticoagulant Reversal Drugs Market - Japan
      • 7.5.6.1. Japan: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.5.6.2. Japan: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.5.7. Anticoagulant Reversal Drugs Market - Indonesia
      • 7.5.7.1. Indonesia: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.5.7.2. Indonesia: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.5.8. Anticoagulant Reversal Drugs Market - South Korea
      • 7.5.8.1. South Korea: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.5.8.2. South Korea.: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • 7.6. Anticoagulant Reversal Drugs Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
    • 7.6.2. Middle East & Africa.: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.6.3. Anticoagulant Reversal Drugs Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.6.3.2. Saudi Arabia.: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.6.4. Anticoagulant Reversal Drugs Market - UAE
      • 7.6.4.1. UAE: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.6.4.2. UAE: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.6.5. Anticoagulant Reversal Drugs Market - Israel
      • 7.6.5.1. Israel: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.6.5.2. Israel: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.6.6. Anticoagulant Reversal Drugs Market - South Africa
      • 7.6.6.1. South Africa: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.6.6.2. South Africa: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
  • 7.7. Anticoagulant Reversal Drugs Market - Latin America
    • 7.7.1. Latin America: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
    • 7.7.2. Latin America: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.7.3. Anticoagulant Reversal Drugs Market - Mexico
      • 7.7.3.1. Mexico: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.7.3.2. Mexico.: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.7.4. Anticoagulant Reversal Drugs Market - Brazil
      • 7.7.4.1. Brazil: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.7.4.2. Brazil.: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)
    • 7.7.5. Anticoagulant Reversal Drugs Market - Argentina
      • 7.7.5.1. Argentina: Anticoagulant Reversal Drugs Market, By Product Type, 2016 - 2028 (USD Million)
      • 7.7.5.2. Argentina.: Anticoagulant Reversal Drugs Market, By Distribution Channel, 2016 - 2028 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisition
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Portola Pharmaceuticals
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Boehringer Ingelheim
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. CSL Behring
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bausch Health Companies Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Octapharma AG
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Developmen
  • 9.6. SGPharma Pvt. Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Alps Pharmaceutical Ind. Co., Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Fresenius Kabi AG
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Pfizer, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. AMAG Pharmaceuticals, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Dr. Reddy's Laboratories
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development